Whatever its intensity, it should never be considered "normal." To understand why erections can become painful, it's helpful ...
BMS presented trial results from mezigdomide and arlocabtagene autoleucel at EHA 2026. Credit: Tada Images/Shutterstock.com. Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline ...
New Technology Expands Daxor’s Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and ...
Editors’ Note: On December 17, 2020, the New England Journal of Medicine published a research letter, “Racial Bias in Pulse Oximetry Measurement,” prompted by this essay. Read the medical study here ...
A New Method and a Non-Invasive Device to Estimate Anemia Based on Digital Images of the Conjunctiva
Abstract: Medical practice for determining haemoglobin (Hb) concentration, which is important for anemic patients in need of blood transfusion, requires a blood sample. In this paper, we propose a non ...
During a live event, Andrew Brunner, MD, and participants discussed escalating therapy in luspatercept-refractory LR-MDS. For patients with lower-risk myelodysplastic syndromes (LR-MDS) and ...
Dependability,Machine Learning,Confusion Matrix,Efficacy In Models,Gradient Boosting,Learning Algorithms,Random Forest,Receiver Operating Characteristic Curve,Support Vector Machine,Absence Of Disease ...
Feb. 21, 2026 Running extreme distances may strain more than just muscles and joints. New research suggests ultramarathons can alter red blood cells in ways that make them less flexible and more prone ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
The hematopoietic stem cell transplantation market is experiencing steady growth, driven by the rising prevalence of hematologic malignancies, advances in transplant techniques, donor matching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results